Donepezil vs rivastigmine in Alzheimer's disease - same benefits, different downsides

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1300, 2001-01, pp. : 11-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Donepezil is better tolerated than rivastigmine in mild-to-moderate Alzheimer's disease

By  

Inpharma, Vol. 1, Iss. 1258, 2000-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Galantamine vs Donepezil in the Treatment of Alzheimer's Disease

By Goldlist B.   Gordon M.   Naglie G.  

Drugs & Aging, Vol. 20, Iss. 15, 2003-01 ,pp. : 1139-1140

Adis International

Access to resources Recommend Favorite

Donepezil - benefits extend to advanced Alzheimer's disease?

By  

Inpharma, Vol. 1, Iss. 1236, 2000-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite

Drug Persistency of Two Cholinesterase Inhibitors: Rivastigmine versus Donepezil in Elderly Patients with Alzheimer’s Disease

By Suh Dong-Churl  

Drugs & Aging, Vol. 22, Iss. 8, 2005-01 ,pp. : 695-707

Adis International

Access to resources Recommend Favorite

Use of Antipsychotic Drugs in Patients with Alzheimer's Disease Treated with Rivastigmine versus Donepezil: A Retrospective, Parallel-Cohort, Hypothesis-Generating Study

By Scharre Douglas W.  

Drugs & Aging, Vol. 27, Iss. 11, 2010-11 ,pp. : 903-913

Adis International

Access to resources Recommend Favorite